Captain's Quarters

[OCKHAM'S RAZOR]

SAFC " explosive " move could be happening here.

*2 FDA approved technologies

The company's new technology is fully approved by the Federal Drug Administration (FDA), and has demonstrated itself to be safe and effective in actively reducing pain during the administration of blood tests, lanching and injections - a daily reality for many during ongoing medical care.

Both EZJect and Quickool - the newly acquired technologies - received FDA approval for commercialization in 2007.

"To acquire technology that already has FDA approval, is a major step toward full commercialization in the United States," said Akiva Schonfled, Chief Executive Officer of SafeCode Drug Technologies. "These technologies have applications in hospitals, doctor's offices and clinics, in addition to the at-home, individual care markets. We are confident that with the right project manager in place, we can implement a winning commercialization strategy."

http://finance.yahoo.com/news/safeco-receives-investment-biomedix-194240945.html

$SAFC



##### recent news/filings ~ source: finance.yahoo.com

Fri, 17 May 2013 17:04:44 GMT ~ SAFECODE DRUG TECHNOLOGIES CORP. Financials
read full: http://finance.yahoo.com/q/is?s=safc
*********************************************************

Fri, 10 May 2013 03:58:47 GMT ~ SAFECODE DRUG TECHNOLOGIES CORP. Files SEC form 10-Q, Quarterly Report
read full: http://biz.yahoo.com/e/130510/safc10-q.html
*********************************************************

Wed, 17 Apr 2013 12:30:00 GMT ~ SafeCode Drug Technologies to Hire Project Manager to Market FDA Approved Painless Injection Device
[PR Newswire] - JERUSALEM, April 17, 2013 /PRNewswire/ -- SafeCode Drug Technologies Corp. (OTCBB: SAFC), a developer of technologies that reduces errors and eliminates pain during the administration of prescription medications, ...
read full: http://finance.yahoo.com/news/safecode-drug-technologies-hire-project-123000318.html
*********************************************************

Mon, 08 Apr 2013 06:29:04 GMT ~ SAFECODE DRUG TECHNOLOGIES CORP. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements
read full: http://biz.yahoo.com/e/130408/safc8-k.html
*********************************************************

Mon, 25 Mar 2013 03:10:27 GMT ~ SAFECODE DRUG TECHNOLOGIES CORP. Files SEC form 10-K, Annual Report
read full: http://biz.yahoo.com/e/130325/safc10-k.html
*********************************************************

##### chart ~ source: stockcharts.com



##### chart ~ source: eoddata.com



##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/SAFC/company-info
Ticker: $SAFC
OTC Market Place: OTCQB
CIK code: 0001508470
Company name: SafeCode Drug Technologies Corp.
Incorporated In: DE, USA

##### extra dd links

Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001508470&owner=exclude&count=40
Latest filings: http://www.otcmarkets.com/stock/SAFC/filings
Latest financials: http://www.otcmarkets.com/stock/SAFC/financials
Latest news: http://www.otcmarkets.com/stock/SAFC/news - http://finance.yahoo.com/q/h?s=SAFC+Headlines
Major holdings: http://data.cnbc.com/quotes/SAFC/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=SAFC+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/SAFC.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=SAFC
RegSho: http://www.regsho.com/tools/symbol_stats.php?sym=SAFC&search=search
DTCC: http://search2.dtcc.com/?q=SafeCode+Drug+Technologies+Corp.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&q=SafeCode+Drug+Technologies+Corp.
Corporation WIKI: http://www.corporationwiki.com/search/results?term=SafeCode+Drug+Technologies+Corp.&x=0&y=0

##### last known share structure ~ source: otcmarkets.com

Market Value: $258,199 a/o Jul 15, 2013
Shares Outstanding: 107,582,851 a/o Mar 31, 2013
Float: Not Available
Authorized Shares: 200,000,000 a/o Dec 31, 2011
Par Value: 0.0001

##### business description ~ source: otcmarkets.com





ARTICLE 2: LICENSE CONSIDERATION

Section 2.1 In consideration for the grant of the License by the Licensor, Licensee shall issue Licensor an aggregate of 10,000,000 restricted shares of Licensee's common stock, par value $0.0001 per share ("Shares"), valued for the purposes of this License Agreement at a price of $0.70 per Share ("Valuation Price").